Read Pharmaceutical news articles from recent Pharmaceutical headlines
 
Google
Home » Pharmaceutical Articles » Recall Issued for Digitek Digoxin Tablets


Recall Issued for Digitek Digoxin Tablets

Digitek is commonly prescribed as a treatment for heart failure and abnormal heart rhythms. If you have been taking Digitek, you should stop immediately and consult your doctor to make sure you have not suffered any adverse side effects from taking this dangerous drug!

    ORLANDO, FL, April 04, 2009 /Pharmaceutical PR News/ -- Actavis Totowa, the pharmaceutical company that manufactures Digitek digoxin tablets, has issued a recall for the product after it was discovered that many tablets contain a double dose of digoxin. An overdose of this drug can have catastrophic consequences for patients, including nausea, vomiting, low blood pressure, cardiac instability, bradycardia, and in severe cases, death.

Digitek is commonly prescribed as a treatment for heart failure and abnormal heart rhythms. If you have been taking Digitek, you should stop immediately and consult your doctor to make sure you have not suffered any adverse side effects from taking this dangerous drug.

This is not the first time Digitek has made major news headlines. In the 1980's and 90's, a male nurse used the drug to commit a series of murders in an attempt to end his patients' suffering.

The Food and Drug Administration (FDA) has placed Digitek on its MedWatch program. If you have suffered an injury or illness from this drug, it is important to report it to the FDA as soon as possible.

Contracting an illness from a recalled drug is frequently a cause for filing a personal injury lawsuit against the pharmaceutical company. It is important to consult an experienced personal injury lawyer to see if you have a valid claim. You may be entitled to receive compensation for your damages.

If you have been taking Digitek digoxin tablets in the Orlando, Florida area and believe that you have a defective drug claim, please contact the law offices of Colling, Gilbert, Wright & Carter today to schedule an initial consultation.

Source: Colling, Gilbert, Wright & Carter
Website: http://www.thefloridafirm.com


---
Press release service and press release distribution provided by http://www.24-7pressrelease.com
Press Release Contact Information:

Sara Goldstein
ePR Source
submission staff
17301 W. Colfax Ave Suite 275
Golden, CO
USA 80401
Voice: 303-384-9710
 
 
PHARMACEUTICAL ARCHIVE SEARCH
 
SUBMIT PHARMACEUTICAL NEWS
Submit your Pharmaceutical story